GLP1R and type 2 diabetes mellitus: Glucagon-like peptide 1 receptor (GLP-1R) agonists and dipeptidyl peptidase-4 inhibitors (DPP-4i) are approved drugs for the treatment of hyperglycemia in patients with type 2 diabetes (T2D) [1].